Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		A Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse

		Phase:		Phase 2

		Treatment ID#:		1885

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed Recurrent Glioblastoma first or 2nd progression

		Last Updated:		06/29/2009

		Tumor Types:		Glioblastoma Multiforme


		Comments:

		Treatment Type:		Chemotherapy

		Contact:		David Schiff MD Co-Director, Division of Neuro-Oncology University of Virginia Health System Department of Neurology Box 800432 Charlottesville, VA 22908-0432 USA Phone: 434-982-4415 Fax: 434-982-4467 E-mail: ds4jd@virginia.EDU Website: www.uvabraintumor.com

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By